Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
LRMR similar filings
- 10 Aug 23 Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
- 25 Jul 23 Top-line safety, pharmacokinetic, and pharmacodynamic (frataxin level) data from Phase 2 trial’s 50 mg cohort expected in 1H 2024
- 17 Jul 23 Larimar Therapeutics Appoints Dr. Rusty Clayton as Chief Medical Officer
- 1 Jun 23 June 2023 Larimar Therapeutics Corporate Presentation
- 15 May 23 Results of Operations and Financial Condition
- 12 May 23 Submission of Matters to a Vote of Security Holders
- 6 Apr 23 Departure of Directors or Certain Officers
Filing view
External links